Naloxone for opioid-exposed newborn infants
نویسندگان
چکیده
منابع مشابه
Naloxone for narcotic exposed newborn infants: systematic review.
BACKGROUND Naloxone, a specific opiate antagonist, is available for the treatment of newborn infants with respiratory depression that may be due to transplacentally acquired opiates. AIMS To determine if this treatment has any clinically important benefits, and whether there are any harmful effects. METHODS Randomised controlled trials that compared naloxone with placebo or no drug for newb...
متن کاملHeart rate variability in cocaine-exposed newborn infants.
BACKGROUND Infants born to cocaine-using mothers have a 3- to 8-fold increase in sudden infant death syndrome. Its underlying cause, in part, may be attributed to abnormal autonomic function. We proposed to study heart rate variability, reflecting autonomic control of the heart, in cocaine-exposed infants. METHODS From 1997 to 2000, we studied 217 asymptomatic, term infants, of whom 68 had in...
متن کاملNewborn Hearing Screenings in Human Immunodeficiency Virus-Exposed Uninfected Infants
Perinatal HIV infection and congenital cytomegalovirus (CMV) infection may increase the risk for hearing loss. We examined 1,435 infants enrolled in the Surveillance Monitoring of ART Toxicities (SMARTT) study of the Pediatric HIV/AIDS Cohort Study (PHACS) network, a prospective study of the safety of in utero antiretroviral (ARV) exposures. We determined the proportion of perinatally HIV-expos...
متن کاملCaged naloxone reveals opioid signaling deactivation kinetics.
The spatiotemporal dynamics of opioid signaling in the brain remain poorly defined. Photoactivatable opioid ligands provide a means to quantitatively measure these dynamics and their underlying mechanisms in brain tissue. Although activation kinetics can be assessed using caged agonists, deactivation kinetics are obscured by slow clearance of agonist in tissue. To reveal deactivation kinetics o...
متن کاملOral naloxone reverses opioid-associated constipation.
Opioid-related constipation is one of the most frequent side effects of chronic pain treatment. Enteral administration of naloxone blocks opioid action at the intestinal receptor level but has low systemic bioavailability due to marked hepatic first-pass metabolism. The aim of this study was to examine the effects of oral naloxone on opioid-associated constipation in an intraindividually contro...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cochrane Database of Systematic Reviews
سال: 2018
ISSN: 1465-1858
DOI: 10.1002/14651858.cd003483.pub3